IL70471A - Isocyanate prepolymers for dermal and transdermal therapy - Google Patents

Isocyanate prepolymers for dermal and transdermal therapy

Info

Publication number
IL70471A
IL70471A IL70471A IL7047183A IL70471A IL 70471 A IL70471 A IL 70471A IL 70471 A IL70471 A IL 70471A IL 7047183 A IL7047183 A IL 7047183A IL 70471 A IL70471 A IL 70471A
Authority
IL
Israel
Prior art keywords
dermal
skin
isocyanate prepolymers
cross
formulations
Prior art date
Application number
IL70471A
Other languages
English (en)
Original Assignee
Sogimi Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sogimi Srl filed Critical Sogimi Srl
Publication of IL70471A publication Critical patent/IL70471A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
    • C08G18/4288—Polycondensates having carboxylic or carbonic ester groups in the main chain modified by higher fatty oils or their acids or by resin acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/30—Low-molecular-weight compounds
    • C08G18/36—Hydroxylated esters of higher fatty acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL70471A 1982-12-17 1983-12-18 Isocyanate prepolymers for dermal and transdermal therapy IL70471A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT24839/82A IT1153909B (it) 1982-12-17 1982-12-17 Polimeri reattivi per la cura di affezioni cutanee

Publications (1)

Publication Number Publication Date
IL70471A true IL70471A (en) 1987-10-20

Family

ID=11214896

Family Applications (1)

Application Number Title Priority Date Filing Date
IL70471A IL70471A (en) 1982-12-17 1983-12-18 Isocyanate prepolymers for dermal and transdermal therapy

Country Status (14)

Country Link
US (1) US4560555A (de)
EP (1) EP0114581B1 (de)
JP (1) JPS59172422A (de)
KR (1) KR840006906A (de)
AT (1) ATE29108T1 (de)
AU (1) AU2248383A (de)
CA (1) CA1244590A (de)
DE (1) DE3373171D1 (de)
DK (1) DK582183A (de)
IE (1) IE56380B1 (de)
IL (1) IL70471A (de)
IT (1) IT1153909B (de)
NZ (1) NZ206586A (de)
ZA (1) ZA839345B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727868A (en) * 1984-11-13 1988-03-01 Thermedics, Inc. Anisotropic wound dressing
US4751133A (en) * 1984-11-13 1988-06-14 Thermedics, Inc. Medical patches and processes for producing same
US4880690A (en) * 1984-11-13 1989-11-14 Thermedics, Inc. Perfume patch
JPS61249474A (ja) * 1985-04-25 1986-11-06 サ−メデイクス　インコ−ポレイテド 異方性医用被覆材
US4752472A (en) * 1986-03-25 1988-06-21 Exovir, Inc. Cosmetic skin treatment useing cyanoacrylate polymer film
US4743632A (en) * 1987-02-25 1988-05-10 Pfizer Hospital Products Group, Inc. Polyetherurethane urea polymers as space filling tissue adhesives
ES2026990T3 (es) * 1988-01-07 1992-05-16 Exovir, Inc. Tratamiento cosmetico de la piel.
GB8815435D0 (en) * 1988-06-29 1988-08-03 Smith & Nephew Non autoadherent dressings
US4972848A (en) * 1989-08-23 1990-11-27 Medtronic, Inc. Medical electrical lead with polymeric monolithic controlled release device and method of manufacture
IL94910A (en) * 1990-06-29 1994-04-12 Technion Research Dev Foundati Biomedical adhesive compositions
DE19654468C1 (de) 1996-12-27 1998-01-22 Lohmann Therapie Syst Lts Extrem flexibles, dermal oder transdermal wirkendes Pflaster und Verfahren zu seiner Herstellung
EP1104297B8 (de) * 1998-07-09 2006-05-03 Cephalon, Inc. Zusammensetzungen zur behandlung chronischer lymphatischer leukämie
US7129262B2 (en) * 1999-07-23 2006-10-31 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7105560B1 (en) 1999-07-23 2006-09-12 The Regents Of The University Of California Use of etodolac in the treatment of multiple myeloma
US7151100B1 (en) * 1999-07-23 2006-12-19 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7361680B2 (en) * 1999-07-23 2008-04-22 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US6545034B1 (en) * 1999-07-23 2003-04-08 The Regents Of The University Of California Use of etodolac for the treatment of chronic lymphocytic leukemia
US6403063B1 (en) 1999-07-26 2002-06-11 Kenneth I. Sawyer Method of treating nail fungus
US6337076B1 (en) * 1999-11-17 2002-01-08 Sg Licensing Corporation Method and composition for the treatment of scars
US7736661B1 (en) * 2000-03-07 2010-06-15 Avon Products, Inc Method of treating skin conditions
US20040152672A1 (en) * 2000-08-09 2004-08-05 Carson Dennis A. Indole compounds useful for the treatment of cancer
WO2002072059A2 (en) 2001-03-07 2002-09-19 The Procter & Gamble Company Topical composition comprising a functionally alkylating cosmetic bonding agent
EP1370235A2 (de) 2001-03-07 2003-12-17 The Procter & Gamble Company Kosmetische zusammensetzungen zur topischen anwendung enthaltend aldehyd- oder keton-funktionalitäten aufweisende agentien
EP1367990A2 (de) 2001-03-07 2003-12-10 The Procter & Gamble Company Kosmetische zusammensetzungen zur topischen anwendung enthaltend funktionalisierte acylierende agentien
CN1496249A (zh) 2001-03-07 2004-05-12 包括基于三元环状化合物的化妆品键合剂的局部组合物
CN1496252A (zh) * 2001-03-07 2004-05-12 包括1,2-杂原子组成的双烯化妆品键合剂的局部组合物
WO2002096372A2 (en) 2001-05-30 2002-12-05 The Procter & Gamble Company Topical composition comprising an activated, trans-structured cosmetic bonding agent
MXPA03010860A (es) 2001-05-30 2004-02-17 Procter & Gamble COMPOSICION TOPICA QUE COMPRENDE UN AGENTE DE UNION COSMeTICO SUSTITUIDO.
US6585967B2 (en) 2001-07-05 2003-07-01 Closure Medical Corporation Adhesive treatment for tinea cruris
US6602496B2 (en) 2001-07-05 2003-08-05 Closure Medical Corporation Adhesive treatment for tinea corporis
US6767552B2 (en) 2001-07-05 2004-07-27 Closure Medical Corporation Adhesive treatment for oral fungal infection
US6942875B2 (en) * 2001-07-05 2005-09-13 Closure Medical Corporation Adhesive treatment for skin yeast infections
US6746667B2 (en) 2001-07-05 2004-06-08 Closure Medical Corporation Adhesive treatment for tinea pedis
US6750291B2 (en) * 2002-04-12 2004-06-15 Pacific Corporation Film-forming agent for drug delivery and preparation for percutaneous administration containing the same
US20060216267A1 (en) * 2002-08-20 2006-09-28 Kovacs Stephen G Hydrophobic elastomeric polymer chemistry device for inhibiting the growth of onychomycosis and urushiol-induced allergic contact dermatitis
US7402323B2 (en) * 2002-08-21 2008-07-22 Akpharma, Inc. Compositions and methods for treating skin conditions
US7211599B2 (en) * 2002-09-19 2007-05-01 The Regents Of The University Of California Use of etodolac to treat hyperplasia
US7569612B1 (en) 2006-08-21 2009-08-04 Mutual Pharmaceutical Company, Inc. Methods of use of fenofibric acid
US20080107743A1 (en) * 2006-11-02 2008-05-08 Akpharma Inc. Composition and method for enhancing skin cell growth, proliferation and repair
US20100255070A1 (en) * 2007-05-22 2010-10-07 Prelief Inc. Compositions and methods for preventing, minimizing and healing skin irritation and trauma
US8771725B2 (en) * 2007-10-12 2014-07-08 Chesson Laboratory Associates, Inc. Poly(urea-urethane) compositions useful as topical medicaments and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3526224A (en) * 1967-06-08 1970-09-01 Johnson & Johnson Dressing
DE2105062C3 (de) * 1971-02-04 1980-01-24 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Überzügen unter Verwendung von Zweikomponenten-Polyurethanlacken
DE2304893B1 (de) * 1973-02-01 1974-03-14 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Überzügen
US4250267A (en) * 1977-11-10 1981-02-10 W. R. Grace & Co. Immobilized biological material

Also Published As

Publication number Publication date
IE832970L (en) 1984-06-17
DK582183A (da) 1984-06-18
US4560555A (en) 1985-12-24
IT1153909B (it) 1987-01-21
IT8224839A0 (it) 1982-12-17
ZA839345B (en) 1984-08-29
EP0114581A1 (de) 1984-08-01
AU2248383A (en) 1984-06-21
DE3373171D1 (en) 1987-10-01
IE56380B1 (en) 1991-07-17
EP0114581B1 (de) 1987-08-26
CA1244590A (en) 1988-11-08
KR840006906A (ko) 1984-12-04
NZ206586A (en) 1987-07-31
ATE29108T1 (de) 1987-09-15
JPS59172422A (ja) 1984-09-29
DK582183D0 (da) 1983-12-16
IT8224839A1 (it) 1984-06-17

Similar Documents

Publication Publication Date Title
IL70471A (en) Isocyanate prepolymers for dermal and transdermal therapy
DE69529577D1 (de) Prophylaktische und therapeutische behandlung von haupt sensibilisierung und -reizung
GB2088209B (en) Composition for the treatment of keratin fibres based on amphoteric polymers and anionic polymers
ATE82133T1 (de) Verwendung von einem cartilago-induzierenden faktor (cif) zur herstellung eines arzneimittels zur behandlung von entzuendungen.
DE3751044D1 (de) Absorbierendes Material mit hoher Verdichtung, versehen mit Zonen niedriger Verdichtung und niedrigem spezifischem Gewicht sowie dieses Material enthaltende Produkte.
NO951592L (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system
AT368391B (de) Verwendung von vernetzten polymeren als verdickungsmittel zur herstellung von kosmetischen, pharmazeutischen und technischen praeparaten
EP0388306A3 (de) Verfahren zur Behandlung von mit Herpes-Zoster assoziierten Schmerzen und von postherpetischen Neuralgien mittels topikaler Anwendung von Lokalanästhetika
PT671910E (pt) Utilizacao de derivados de adamantano no fabrico de um medicamento para o tratamento do glaucoma
EP0147261A3 (en) Medicine and medicinal composition for the treatment and the prevention of skin affections involving an inflammation process
AU497383B2 (en) Method and bandage for administering scopolamine transdermally
IE40860L (en) N- heterocyclylalkylbenzamides
EP0214254A1 (de) Melatoninhaltige mittel sowie deren verwendungen.
CA960924A (en) Penetrating treatment for wood plastic composites and treated composites
ES540447A0 (es) Un metodo de preparar un vendaje
GB2347625A (en) Agent for treating allergic or hypersensivity condition
CZ8595A3 (en) The use of dimerized form of lysozyme for preparing medicaments and pharmaceutical preparations, injection solutions, tampons and antiseptic bandages
AU7245581A (en) Polymer compositions and treatment of tumours
AU6278680A (en) Carbamates and pharmaceutical formulations containing them
DE3268159D1 (en) Medicaments based on algae, and formulations thereof
PT65737B (en) Process for the preparation of disubstituted phenol ethersof 3-amino-2-hydroxypropane with cerebrovascular activity application of same for the preparation of pharmaceutical compositions with cerebrovascular activity and applicationof these pharmaceutical compositions in the treatment of cerebrovascular insufficiency
CA2257875A1 (en) Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders
AU487794B2 (en) Method for treating fluid-discharging skin surfaces, wounds, sores, and mucous membranes andthe means for carrying out the method
AU6467574A (en) Method for treating fluid-discharging skin surfaces, wounds, sores, and mucous membranes andthe means for carrying out the method
AU7356474A (en) Cure for eczema, burns, corns and other irritations of the skin

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees